Indication

Complicated skin and skin structure Streptococcus agalactiae infection

A complicated skin and skin structure *Streptococcus agalactiae* infection refers to a severe bacterial invasion of the integumentary and underlying soft tissues caused by *Streptococcus agalactiae* (Lancefield group B Streptococcus). Read more about Complicated skin and skin structure Streptococcus agalactiae infection

107 drugs 72 manufacturers

Advertisement

Drugs that treat it

Common Complicated skin and skin structure Streptococcus agalactiae infection therapies.

Showing 10–18 of 107 drugs

LINEZOLID

OXAZOLIDINEDIONES·VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
GREENSTONE LLC.

LINEZOLID

VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
ROXANE LABS.

LINEZOLID

VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
Mylan Pharmaceuticals

LINEZOLID

OXAZOLIDINEDIONES·VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
Major Pharamceuticals

LINEZOLID

OXAZOLIDINEDIONES·VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
CAMBER PHARMACE

LINEZOLID

OXAZOLIDINEDIONES·VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
GREENSTONE LLC.

LINEZOLID

OXAZOLIDINEDIONES·VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
ASCEND LABORATO
Filter & compare in the drug finder →Opens the drug finder with Complicated skin and skin structure Streptococcus agalactiae infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Complicated skin and skin structure Streptococcus agalactiae infection.

A complicated skin and skin structure *Streptococcus agalactiae* infection refers to a severe bacterial invasion of the integumentary and underlying soft tissues caused by *Streptococcus agalactiae* (Lancefield group B Streptococcus).

This clinical entity primarily involves the deep subcutaneous tissues, fascia, or muscle beds, presenting as extensive cellulitis, major abscesses, infected surgical wounds, or infected decubitus and diabetic ulcers.

Infections disproportionately affect adult populations with predisposing systemic conditions, such as diabetes mellitus, advanced age, peripheral vascular compromise, or immunosuppression.

Pathophysiologically, the organism establishes invasive tissue necrosis and acute inflammation characterized by expanding erythema, induration, localized pain, and purulence, which frequently necessitate systemic antibiotic therapy alongside surgical debridement or drainage due to significant risks of deep tissue destruction and bacteremia.

Personalize your experience

Follow Complicated skin and skin structure Streptococcus agalactiae infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it